Figure 3From: Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patientsClinical courses after lamivudine cessation in initial HBeAg-positive patients according to serologic response. Virologic relapse (A), biochemical breakthrough (B), and hepatitis flare (C).Back to article page